Chelating Agent Effect on the Release of Gentamicin from PEG-DA Hydrogels

Yıl 2008, Cilt: 36 Sayı: 4, 347 - 352, 01.12.2008

Nazlı Sökmen Ferah Bican Fatma Ayhan Hakan Ayhan

Öz

In this study, controlled drug release devices of poly ethylene glycol-diacrylate PEG-DA hydrogels were preparedby free radical UV polymerization. PEG-DA macromere was cross-linked with different percentages of ethylene glycoldimethacrylate EGDMA . The chelating agent, ethylene diamine tetraacetic acid EDTA , was added at three differentconcentrations. Gentamicin sulphate was incorporated into the hydrogel during photopolymerization and its releasekinetics was tested spectrophotometrically at 255 nm in phosphate buffer pH 7.4 . Results indicate that the presenceof chelating agent leads to a prolonged drug release. Gentamicin release from hydrogel synthesized by using lowchelating and cross-linking agent concentrations indicate slow release time. The effect of chelating agentconcentration eliminated when the amount of cross-linking agent increased while drug release time is still higher thancontrol group which was prepared in the absence of EDTA. It is interesting to note that the gentamicin release timeprolonged when chelating agent decreased at constant cross-linking agent concentration

Anahtar Kelimeler

Chelating agent, PEG-DA, ethylene diamine tetraacetic acid EDTA, Hydrogel

Kaynakça

• 1. Peppas N.A., Ward, J.H. Preparation of controlled release systems by free – radical UV polymerizations in the presence of a drug, Journal of Controlled Release, 711: 183-192, 2001.
• 2. Kanjickal, D.G., Lopina, S.T., Modeling of drug release from polymeric delivery systems—a review, Crit. Rev. Ther. Drug Carr. Syst. 21: 345–386, 2004.
• 3. Scott, R.A., Peppas, N.A., Highly crosslinked, PEG-containing copolymers for sustained solute delivery, Biomaterials, 20: 1371-1380, 1999.
• 4. Hoffman, A.S. Hydrogels for biomedical applications. Advanced Drug Delivery Reviews, 43: 3-12, 2002.
• 5. Nguyen, K.T., West, J.L., Photopolymerizable hydrogels for tissue engineering applications, Biomaterials, 23: 4307–4314, 2002.
• 6. Kost, J., Langer, R., Responsive polymeric delivery systems, Advanced Drug Delivery Reviews, 46: 125–148, 2001.
• 7. Francis, S., Varshney, L., Studies on radiation synthesis of PVA/EDTA hydrogels, Radiation Physics and Chemistry, 74: 310 – 316, 2001.
• 8. Otto J. Grundler, Arnold T.M van der Steen, Joel Wilmot., Overview of the European Risk Assessment on EDTA, ACS Symposium Series 910, 336-347, 2005.
• 9. Bernd Nörtemann, Biodegradation of Chelating Agents: EDTA, DTPA, PDTA, NTA and EDDS, ACS Symposium Series 910, 150-170, 2005.
• 10. Brend Nowack, Jeanne M. Van Briesen, Chelating Agents in the Environment, ACS Symposium Series 910, 1-18, 2005.
• 11. Bucheli-Witschel, M., Egli, T. Environmental fate and microbial degradation of aminopolycarboxylic acids, FEMS Microbiology Reviews, 25: 69-106, 2001.
• 12. Changez M., Burugapalli K., Koul V., Choudhary V., The effect of composition of poly (acrylic acid)- gelatin hydrogel on gentamicin sulphate release: in vitro, Biomaterials, 24: 527-536, 2003.
• 13. Anseth K.S., Bryant S.J., The Effects of scaffold thickness on tissue engineered cartilage in photocrosslinked poly(ethylene oxide) hydrogels, Biomaterials, 22: 619-626, 2001.
• 14. Ayhan F., Özkan S., Gentamicin Release from Photopolymerized PEG Diacrylate and PHEMA Hydrogel Discs and Their In Vitro Antimicrobial Activities, Drug Delivery, 14: 433-439, 2007.